Skip to Main Content

And so, another working week is about to come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We hope to tidy up around the Pharmalot campus, catch up on some reading, and prep for the annual Woodstock-like gathering for biopharma enthusiasts next week. And what about you? In some locales, you may want to make sure your pipes are warm (no double entendre implied). You could calculate the impact of the tax bill. Or plan the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy and see you soon …

Prescriptions for nerve pain medicines like Neurontin and Lyrica have more than tripled in recent years, driven by increased use among chronically ill older adults and patients already taking opioids, Reuters tells us, citing a study in JAMA Internal Medicine. The proportion of U.S. adults prescribed gabapentinoids climbed from 1.2 percent in 2002 to 3.9 percent by 2015, a period that also saw a surge in opioid overdoses and deaths.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!